Jessica E. Pittman

Washington University in St. Louis — United States

Medicine · Health Sciences

22h-index3.2kcitations72works6.62yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cystic Fibrosis Research Advances(50), Neonatal Respiratory Health Research(37), Tracheal and airway disorders(18), Pediatric health and respiratory diseases(14), Respiratory viral infections research(8)

Publications71 total

Elexacaftor/tezacaftor/ivacaftor is associated with long-term reduction in use of chronic respiratory therapies in cystic fibrosis
Journal of Cystic Fibrosis·2025· 3 cited
Airway Disease Progression on Chest Computed Tomography in Children With Primary Ciliary Dyskinesia
Pediatric Pulmonology·2025· 2 cited
Clinical Effectiveness of Elexacaftor/Tezacaftor/Ivacaftor in 6- to 11-Year-Olds with Cystic Fibrosis: An Observational Study
Annals of the American Thoracic Society·2025· 3 citedOpen Access
Vanzacaftor–tezacaftor–deutivacaftor for children aged 6–11 years with cystic fibrosis (RIDGELINE Trial VX21-121-105): an analysis from a single-arm, phase 3 trial
The Lancet Respiratory Medicine·2025· 41 citedOpen Access
Comparison of Longitudinal Outcomes in Children with Primary Ciliary Dyskinesia and Cystic Fibrosis
Annals of the American Thoracic Society·2024· 4 citedOpen Access
P236 Investigating the impact of elexacaftor/tezacaftor/ivacaftor therapy on longitudinal oropharyngeal microbiome dynamics in children with cystic fibrosis
Journal of Cystic Fibrosis·2024
Automated Analysis of Bronchus and Artery Dimensions on Chest Computed Tomography in Children With Primary Ciliary Dyskinesia
2024
Abstract MP46: Recurrent Hypertensive Disorders of Pregnancy and Subsequent Maternal Coronary Heart Disease and Stroke
Circulation·2024
Mo1885 FECAL MICROBIOTA CHANGES IN CHILDREN WITH CYSTIC FIBROSIS WITH 1 MONTH OF CFTR MODULATOR THERAPY ELEXACAFTOR/TEZACAFTOR/IVACAFTOR: PRELIMINARY FINDINGS FROM THE PROMISE PEDIATRICS STUDY
Gastroenterology·2023
Airway Disease Progression on Chest Computed Tomography in Children With Primary Ciliary Dyskinesia
2023
Airway Disease in Children with Primary Ciliary Dyskinesia: Impact of Ciliary Ultrastructure Defect and Genotype
Annals of the American Thoracic Society·2022· 30 citedOpen Access
Elexacaftor/tezacaftor/ivacaftor and gastrointestinal outcomes in cystic fibrosis: Report of promise-GI
Journal of Cystic Fibrosis·2022· 113 citedOpen Access
Impact of azithromycin on serum inflammatory markers in children with cystic fibrosis and new Pseudomonas
Journal of Cystic Fibrosis·2022· 13 citedOpen Access
Morbidity and Mortality in the Obese Trauma Intensive Care Unit Patient
The American Surgeon·2021· 4 cited
Rates of adverse and serious adverse events in children with cystic fibrosis
Journal of Cystic Fibrosis·2021· 4 citedOpen Access
PROMISE: Working with the CF community to understand emerging clinical and research needs for those treated with highly effective CFTR modulator therapy
Journal of Cystic Fibrosis·2021· 67 citedOpen Access
ZMYND10 Is Mutated in Primary Ciliary Dyskinesia and Interacts with LRRC6
UNC Libraries·2020Open Access
Zebrafish Ciliopathy Screen Plus Human Mutational Analysis Identifies C21orf59 and CCDC65 Defects as Causing Primary Ciliary Dyskinesia
UNC Libraries·2020Open Access
Age of Pseudomonas aeruginosa acquisition and subsequent severity of cystic fibrosis lung disease
UNC Libraries·2020· 5 citedOpen Access
Clinical and genetic aspects of primary ciliary dyskinesia/Kartagener syndrome
UNC Libraries·2020Open Access
page 1 of 4Next →

Frequent Co-authors

Stephanie D. Davis(32), Margaret Rosenfeld(27), Margaret W. Leigh(23), Scott D. Sagel(22), Michael R. Knowles(20), Thomas W. Ferkol(17), Carlos Milla(17), Sharon Dell(16), Maimoona A. Zariwala(14), Adam J. Shapiro(12), Kelli M. Sullivan(8), Félix Ratjen(8), Jeffrey P. Krischer(7), Johnny L. Carson(6), Kenneth N. Olivier(6), BreAnna Kinghorn(6), Sonya L. Heltshe(5), Robin Johnson(5), Milan J. Hazucha(4), George M. Solomon(4)